Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Orphan Drug Designation For Remdesivir Is 'Consistent' With Precedent, Former FDA Lawyer Says
Mar 25 2020
•
By
Brenda Sandburg
Gilead's remdesivir receives orphan drug designation for COVID-19
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership